1. Home
  2. AUB vs RYTM Comparison

AUB vs RYTM Comparison

Compare AUB & RYTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AUB
  • RYTM
  • Stock Information
  • Founded
  • AUB 1902
  • RYTM 2008
  • Country
  • AUB United States
  • RYTM United States
  • Employees
  • AUB N/A
  • RYTM N/A
  • Industry
  • AUB Major Banks
  • RYTM Biotechnology: Pharmaceutical Preparations
  • Sector
  • AUB Finance
  • RYTM Health Care
  • Exchange
  • AUB Nasdaq
  • RYTM Nasdaq
  • Market Cap
  • AUB 3.5B
  • RYTM 3.8B
  • IPO Year
  • AUB N/A
  • RYTM 2017
  • Fundamental
  • Price
  • AUB $29.29
  • RYTM $57.38
  • Analyst Decision
  • AUB Buy
  • RYTM Strong Buy
  • Analyst Count
  • AUB 5
  • RYTM 12
  • Target Price
  • AUB $39.00
  • RYTM $75.42
  • AVG Volume (30 Days)
  • AUB 1.9M
  • RYTM 691.8K
  • Earning Date
  • AUB 04-24-2025
  • RYTM 05-07-2025
  • Dividend Yield
  • AUB 4.64%
  • RYTM N/A
  • EPS Growth
  • AUB N/A
  • RYTM N/A
  • EPS
  • AUB 2.15
  • RYTM N/A
  • Revenue
  • AUB $797,879,000.00
  • RYTM $136,863,000.00
  • Revenue This Year
  • AUB $78.93
  • RYTM $43.84
  • Revenue Next Year
  • AUB $15.95
  • RYTM $65.62
  • P/E Ratio
  • AUB $13.61
  • RYTM N/A
  • Revenue Growth
  • AUB 16.62
  • RYTM 48.88
  • 52 Week Low
  • AUB $22.85
  • RYTM $35.17
  • 52 Week High
  • AUB $44.54
  • RYTM $68.58
  • Technical
  • Relative Strength Index (RSI)
  • AUB 58.29
  • RYTM 43.00
  • Support Level
  • AUB $28.42
  • RYTM $62.69
  • Resistance Level
  • AUB $29.64
  • RYTM $65.53
  • Average True Range (ATR)
  • AUB 0.86
  • RYTM 3.04
  • MACD
  • AUB 0.55
  • RYTM -0.73
  • Stochastic Oscillator
  • AUB 91.83
  • RYTM 1.14

About AUB Atlantic Union Bankshares Corporation

Atlantic Union Bankshares Corp is a financial holding company and a bank holding company. Through its community bank subsidiary, the company provides financial services, including banking, trust, and wealth management. The bank is a full-service community bank offering consumers and businesses a wide range of banking and related financial services, including checking, savings, certificates of deposit, and other depository services, as well as loans for commercial, industrial, residential mortgage, and consumer purposes. The company operates through two reportable operating segments: Wholesale Banking and Consumer Banking, with corporate support functions such as corporate treasury and others included in Corporate Other. It derives maximum revenue from Wholesale Banking.

About RYTM Rhythm Pharmaceuticals Inc.

Rhythm Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. It is engaged in the development and commercialization of therapies for patients with rare diseases. The company is focused on its melanocortin-4 receptor (MC4R) agonists, including its lead asset, IMCIVREE (setmelanotide), as a precision medicine designed to treat hyperphagia and severe obesity caused by rare MC4R pathway diseases. Geographically the company generates its revenue from the United States and internationally with the majority being generated from the United States.

Share on Social Networks: